Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Large Cell”

386 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 386 results

Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Early research (Phase 1)Study completedNCT00986297
What this trial is testing

Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00003831
What this trial is testing

Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 1,023
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Large-scale testing (Phase 3)Ended earlyNCT00863512
What this trial is testing

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 34
Large-scale testing (Phase 3)Ended earlyNCT00596830
What this trial is testing

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

Who this might be right for
Carcinoma, Squamous CellCarcinoma, AdenosquamousCarcinoma, Large Cell+1 more
Pfizer 681
Testing effectiveness (Phase 2)Ended earlyNCT00003492
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Who this might be right for
Stage IV Lung Cancer
Burzynski Research Institute 9
Testing effectiveness (Phase 2)Study completedNCT00234052
What this trial is testing

Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University 51
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00278460
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 49
Testing effectiveness (Phase 2)Study completedNCT00117962
What this trial is testing

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Early research (Phase 1)Not Yet RecruitingNCT07583771
What this trial is testing

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

Who this might be right for
Pancreatic AdenocarcinomaNon Small Cell Lung CancerAdvanced Solid Tumors+2 more
Chipscreen Biosciences, Ltd. 186
Not applicableWithdrawnNCT01875549
What this trial is testing

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

Who this might be right for
Obstruction of Biliary TreeCholangiocarcinomaHepatocellular Carcinoma+2 more
Kwang Hyuck Lee
Testing effectiveness (Phase 2)Study completedNCT00002577
What this trial is testing

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 36
Not applicableUnknownNCT00242983
What this trial is testing

Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Hospital Organization Kinki-chuo Chest Medical Center
Not applicableStudy completedNCT01720706
What this trial is testing

Thermal Ablation in Larger Liver and Kidney Tumours

Who this might be right for
Liver and Kidney Tumours
University Health Network, Toronto 12
Early research (Phase 1)Ended earlyNCT00042835
What this trial is testing

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Study completedNCT02535325
What this trial is testing

Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Adenocarcinoma AJCC v7Stage III Lung Large Cell Carcinoma AJCC v7+10 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00365547
What this trial is testing

Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 46
Next Page